PREVIOUS
✖
Global Initiative on Sharing All Influenza Data (GISAID)
April 11 , 2020
1564 days
777
0
- India has shared nine whole genome sequences of the novel coronavirus (SARS-CoV-2) with the Global Initiative on Sharing All Influenza Data (GISAID).
- All these have been shared by the Pune-based National Institute of Virology.
- Early in March, India became the fifth country in the world to sequence the genome of the novel Coronavirus, or Covid-19.
- With 621, the U.S. has shared the most number of sequences, followed by the U.K. (350), Belgium (253) and China (242).
- The CCMB (Centre for Cellular and Molecular Biology), CSIR (Council of Scientific and Industrial Research) and IGIB (Institute of Genomics and Integrative Biology) are working on genome sequencing of COVID-19.
- Genomic sequencing is a technique that allows us to read and interpret genetic information found within DNA or RNA.
- It is being done to understand the evolution of the virus.
- Sequencing the genome of SARS-CoV-2 will help understand
- Where the virus came from.
- If there are different strains circulating in India.
- How the virus has spread.
- GISAID is a public platform started by the WHO in 2008 for countries to share genome sequences.
- In 2010 the Federal Republic of Germany became the official host of the GISAID platform.
Leave a Reply
Your Comment is awaiting moderation.